These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 36271288
21. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A. J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666 [Abstract] [Full Text] [Related]
22. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome. Gatta B, Chabre O, Cortet C, Martinie M, Corcuff JB, Roger P, Tabarin A. J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947 [Abstract] [Full Text] [Related]
23. Diagnostic efficacy of midnight cortisol and midnight ACTH in the diagnosis and localisation of Cushing's syndrome. John M, Lila AR, Bandgar T, Menon PS, Shah NS. Pituitary; 2010 Nov; 13(1):48-53. PubMed ID: 19714471 [Abstract] [Full Text] [Related]
28. The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in ACTH-dependent Cushing's syndrome. Qiao J, Li J, Zhang W, Wang C, Li J, Jiang S, Tan H, Chen Y, Liu H, Cai B, Yu Y. Endocr J; 2021 Jul 28; 68(7):839-848. PubMed ID: 33790062 [Abstract] [Full Text] [Related]
29. An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test. Chen K, Chen S, Lu L, Zhu H, Zhang X, Tong A, Pan H, Wang R, Lu Z. Front Endocrinol (Lausanne); 2021 Jul 28; 12():720823. PubMed ID: 34539574 [Abstract] [Full Text] [Related]
30. Low Diagnostic Utility of Overnight High-Dose Dexamethasone Suppression Test in ACTH-Dependent Cushing's Syndrome. Kumar A, Kanwar J, Bharti N, Agrawal V, Bhatia E, Yadav SC. Endocr Pract; 2021 Jul 28; 27(7):723-727. PubMed ID: 34250909 [Abstract] [Full Text] [Related]
35. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome. Montwill J, Igoe D, McKenna TJ. Steroids; 1994 May 28; 59(5):296-8. PubMed ID: 8073441 [Abstract] [Full Text] [Related]
36. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests. Alwani RA, Schmit Jongbloed LW, de Jong FH, van der Lely AJ, de Herder WW, Feelders RA. Eur J Endocrinol; 2014 Apr 28; 170(4):477-86. PubMed ID: 24394725 [Abstract] [Full Text] [Related]
37. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH. Croughs RJ, Zelissen PM, van Vroonhoven TJ, Hofland LJ, N'Diaye N, Lacroix A, de Herder WW. Clin Endocrinol (Oxf); 2000 Feb 28; 52(2):235-40. PubMed ID: 10671952 [Abstract] [Full Text] [Related]
39. [Evaluation of the 1 mg overnight dexamethasone suppression test in the diagnosis of the subclinical Cushing's syndrome in patients with Adrenal Incidentaloma]. Li L, Han B, Dou J, Yang G, Gu W, Lü Z, Mu Y. Zhonghua Yi Xue Za Zhi; 2015 Dec 19; 95(48):3912-6. PubMed ID: 27122212 [Abstract] [Full Text] [Related]